However BACE1 inhibition should not be complete to prevent potential side effects (hypomyelination, schizophrenia- and epileptic-like behaviors, hippocampal neurodegeneration[30-33,210]) linked to BACE1-associated proteolysis of other substrates. Here, BACE1 is linked to schizophrenia.